Company news
Keen Vision Acquisition Corporation news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
July 15, 2025
Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome
June 24, 2025
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
May 19, 2025
Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress
May 12, 2025
Financial Obligation Form 8 K
November 26, 2024
Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
November 4, 2024